Realyze

Realyze Intelligence is a startup operating in the healthcare sector, specifically focusing on improving cancer care. The company's primary objective is to accelerate clinical trials and provide real-world data (RWD), which is information collected outside of traditional clinical trials. This data is crucial in understanding how treatments work in a broader population.

The company serves a market that includes healthcare institutions, research organizations, and patients diagnosed with cancer. It uses advanced artificial intelligence (AI) technology to match patients to clinical trials quickly and efficiently. This not only helps in speeding up the process of clinical trials but also increases the number of patients participating in these trials.

Realyze Intelligence's business model is based on providing a platform that helps attract new patients and boost revenue per patient. By reducing 'leakage' (patients going elsewhere for treatment), diversifying treatment options, and increasing revenue per patient by $150,000 or more, the company helps healthcare institutions increase their profitability.

Moreover, the platform also helps advance institutional reputation and rankings by expanding research capacity, growing revenue from research, and enabling the launch and completion of more trials at a faster pace.

In terms of revenue generation, Realyze Intelligence likely operates on a subscription-based model or charges a fee for its services, although this is not explicitly stated on the website.

Keywords: Healthcare, Cancer Care, Clinical Trials, Real-World Data, Artificial Intelligence, Patient Matching, Revenue Boosting, Research Capacity Expansion, Institutional Reputation, Speedy Trial Completion.